Business Development

For the effective monitoring of global developments in the field of biopharma R&D, GENESIS Pharma has established a specialized Business Development Department which focuses on exploring, identifying and assessing possible future collaborations for products that are either before or in the approval process by the Food and Drug Administration (FDA) or the European Medicines Agency (EMA).  The department plays a key role in coordinating the company’s internal functions in the development of a new partnership.

Over the years, some of the largest biopharmaceutical companies in the world (such as Alnylam, Amicus Therapeutics, Amgen, Biogen, Celgene, CSL Vifor, Incyte, JAZZ Pharmaceuticals) and more recently Kyowa Kirin and Seagen chose to cooperate with GENESIS Pharma acknowledging its expertise in market access, sales, promotion and distribution in the countries in which it operates; as well as GENESIS's commitment to excellence, quality and responsibility.

If you wish to receive more information about GENESIS or organize a meeting please contact our Business Development department on  bd@genesispharmagroup.com